What are the risks and recovery expectations?

Risks include infection, bleeding, and organ toxicity from high-dose chemotherapy, as well as graft failure or autoimmune recurrence. Recovery is gradual: the first 3 months require close monitoring for infections, with most patients returning to daily activities within 6–12 months. Long-term success depends on careful follow-up, but many patients experience sustained remission and improved quality of life.